In the fifteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will revisit the data on chloroquine and hydroxychloroquine in the treatment of COVID-19 and will discuss the data on the effectiveness of hydroxychloroquine in post-exposure prophylaxis. Faculty will also review the recent data on proton pump inhibitors (PPI) and histamine2-receptor antagonists (H2RA) as they relate to COVID-19 risk, giving you the most current information on how to manage your patients taking these medications.

 

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA

Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice and conveys a 4- to 5-fold increased risk of stroke; yet, it often goes undiagnosed and untreated in a primary care setting. In the program, Dr. Ty Gluckman discusses how to recognize patients at high risk for AF, evaluate patients newly diagnosed with AF, assess risk of bleeding and thromboembolism, and apply evidence-based recommendations to reduce thromboembolic risk.

 

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR